

New Evidence Links Viridans Streptococci to Atherosclerosis
Hidden Bacterial Threat in Coronary Plaques
Atherosclerosis has long been understood as a chronic inflammatory process, largely triggered by oxidized LDL. Yet, recent findings published in the Journal of the American Heart Association suggest that oral bacteria, particularly viridans streptococci, may play a more active role than previously assumed.
Researchers analyzing coronary plaques from 121 sudden death autopsies and 96 surgical patients discovered bacterial DNA in over 60% of plaque samples. Notably, viridans streptococci, commonly associated with dental plaque and infective endocarditis, were detected in 42–43% of cases.
Explore All Cardiology CME/CE Conferences and Online Courses
“This evidence suggests that viridans streptococci are not innocent bystanders in the plaque.”
The authors emphasized, pointing toward a possible infection-driven mechanism of plaque instability.
How Oral Bacteria Survive and Trigger Inflammation
Viridans streptococci appear to establish biofilm colonies within arterial walls, effectively evading immune surveillance. Within these biofilms, bacteria remain dormant until triggered, at which point they disperse and activate TLR2-mediated immune pathways.
At rupture-prone plaque sites, dispersed streptococci triggered cytokine release and matrix metalloproteinase (MMP) activity, weakening the fibrous cap and increasing the risk of atherothrombosis and myocardial infarction.
The study highlights that poor dental health and transient bacteremia from routine dental procedures may contribute to bacterial seeding in plaques, raising important clinical considerations for both cardiology and dentistry practices.
Implications for Cardiovascular Care and Research
The association between oral bacteria and cardiovascular events is not entirely new, but this study strengthens the hypothesis that dormant bacterial biofilms can drive plaque vulnerability.
Importantly, the findings align with the broader understanding of inflammation in secondary cardiovascular events, as seen in the CANTOS trial. They also raise the possibility of future interventions, including:
- Targeted antimicrobial therapy during acute myocardial infarction.
- Preventive dental care as a strategy to lower systemic cardiovascular risk.
- Novel diagnostic tools for detecting bacterial biofilms in atherosclerotic plaques.
For healthcare professionals, the message is clear: oral health may be more tightly linked to cardiovascular outcomes than previously recognized.
For More Information
Karhunen, P. J., Pessi, T., Karhunen, V., et al. (2025). Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques. Journal of the American Heart Association. doi: https://doi.org/10.1161/JAHA.125.041521. https://www.ahajournals.org/doi/10.1161/JAHA.125.041521
more recommended stories
Biomarkers: The Future of Liver Transplant Care
Enhancing Patient Care Through Biomarkers More.
Magnetic Nanorobots Enhance Tumor Drug Delivery
Cancer remains one of the leading.
Hospital Meals Strategy Promotes Nutrition and Sustainability
A recent UK study has revealed.
Naloxone Sales Show Initial Surge, Then Decline
Limited uptake raises concerns about accessibility.
U.S. Neonatal Circumcision Rates Drop Over 10 Years
Declining Circumcision Rates Raise Concerns A.
Philippines Strengthens ASF Detection and Control
Innovative Solutions for Rapid ASF Detection.
Key Immune Pathways in Centenarians Identified
Centenarians Offer Clues to Healthy Aging.
Action Video Games and Brain Health: Study Insights
Gaming and Brain Structure: What MRI.
Creatine May Boost Muscle Strength in Alzheimer’s Patients
Creatine Supplementation Shows Promise in Alzheimer’s.
New Drug STF-1623 Shows Promise in Treating Solid Tumors
STF-1623 Transforming ‘Cold’ Tumors into ‘Hot’.
Leave a Comment